Section 3: Implementation Guides
HL7 Guidance: Basic Provenance for C-CDA and FHIR, Release 1 - US Realm
The Basic Provenance Informative guide provides the functional and technical guidance for communicating ‘Minimum Viable Provenance’ in CDA, and FHIR, when information is exchanged.
This informative guide is a prioritized first step towards including more robust provenance in clinical data exchange.
HL7 Guidance: Basic Provenance for C-CDA and FHIR, Release 1 - US Realm may also go by the following names or acronyms:
- Allows systems to trace the history of a clinical data element
Developed and testing in collaboration with HL7 Security and Privacy work group, FHIR connecthaton testing, and the Argonaut community.
ONC published the U.S. Core Data for Interoperability (USCDI) v1 February 2020 , which specifies Provenance alongside data many other data classes and data elements. While many of those data classes have already been defined within the CDA and FHIR standards, “provenance” has not been. For interoperability to be achieved with this data class, functional and technical guidance are needed regarding what details constitute “provenance”, how provenance information should be represented technically in the CDA and FHIR standards, and the best practices around that representation.
|HL7 Guidance: Basic Provenance for C-CDA and FHIR, Release 1 - US Realm||
(Download) (537 KB)
- Security and Privacy
RESPONSIBLE WORK GROUPS
- Implementation Guide
- Clinical and Public Health Laboratories
- Clinical Decision Support Systems Vendors
- EHR, PHR Vendors
- Emergency Services Providers
- Equipment Vendors
- Health Care IT Vendors
- Healthcare Institutions
- HIS Vendors
- Immunization Registries
- Lab Vendors
- Local and State Departments of Health
- Medical Imaging Service Providers
- Pharmaceutical Vendors
- Quality Reporting Agencies
- Regulatory Agency
- Standards Development Organizations (SDOs)
- US Realm